ECT2 and esophageal cancer: Tumor tissue microarray analysis that investigated ECT2 expression in tumors and its prognostic value indicated that this gene is a likely prognostic biomarker and a potential therapeutic target for developing anticancer drugs for lung and esophagus cancers [33].